Weil Company’s Stryker SYK Stock Holding History

Weil Company’s Portfolio SYK Stock Details SYK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-300	Closed	-$65K	–	299
2019 Q3	$65K	Buy	+300	New	+$64.3K	0.05%	168

Other funds holding SYK

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Greenleaf Trust Kalamazoo, Michigan $10.2B AUM 2.09% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Weil Company's SYK Position: Q4 2019 in Review

Weil Company sold out of Stryker (SYK) in Q4 2019, closing a stake of 300 shares — an estimated $65K sold.

Weil Company first reported a position in SYK in Q3 2019 and held it in 1 quarter. The position peaked at $65K in Q3 2019. 1,436 funds tracked by Wall St. Rank hold SYK as of Q4 2019.

Weil Company reported no remaining Stryker position as of Q4 2019 after selling out during the quarter.
Weil Company sold 300 Stryker shares in Q4 2019, an estimated $65K.
Weil Company first reported a position in Stryker in Q3 2019 and held it in 1 quarter.
Weil Company's Stryker position peaked at $65K in Q3 2019.
1,436 funds tracked by Wall St. Rank held Stryker as of Q4 2019.

Based on Weil Company's 13F filing for Q4 2019, filed 13 Feb 2020.